Results 191 to 200 of about 22,541 (295)
Action of dimeric ribonucleases on double‐stranded RNA [PDF]
Giuseppe D’Alessio +2 more
openalex +1 more source
This study identifies a new viral mechanism by a viral protein σ3 that functions as a vTR to suppress NF‐κB gene expression via its direct interaction with the host helicase DHX9. Through their interaction, σ3 not only impairs the initial recruitment of Pol II but also affects Pol II pause‐release and ultimately suppresses NF‐κB gene expression ...
Xueyang Pang +12 more
wiley +1 more source
Involvement of RNase J in CRISPR RNA maturation in the cyanobacterium <i>Synechocystis</i> sp. PCC 6803. [PDF]
Bilger R +7 more
europepmc +1 more source
Molecular Cloning of cDNAs Encoding Ribonuclease-related Proteins inNicotiana glutinosaLeaves, as Induced in Response to Wounding or to TMV-infection [PDF]
Naomi Kurata +3 more
openalex +1 more source
The loss of Ubiquitin Specific Peptidase 26 (USP26) in osteoblasts results in decreased bone formation, as well as multi‐organ fibrosis associated with insulin resistance (IR). Mechanistically, the absence of USP26 reduces glycolysis and lactate accumulation, leading to decreased histone H3 lysine 18 lactylation (H3K18LA) in the promoter region of KH ...
Jiyuan Tang +9 more
wiley +1 more source
Potential function of miRNA as a diagnostic biomarker for human ovarian cancer. [PDF]
Liu F, An Z, Tang C, Han X.
europepmc +1 more source
A post‐stroke perivascular niche of microglia characterized by low expression of M2 markers and elevated glycolysis, oxidative phosphorylation (OXPHOS), and phagocytic activity is identified, which is termed stroke‐activated vascular‐associated microglia (stroke‐VAM).
Yanan Li +8 more
wiley +1 more source
Technologies for Targeted RNA Degradation and Induced RNA Decay. [PDF]
Mikutis S, Bernardes GJL.
europepmc +1 more source
A Rationally Engineered Spleen‐Tropic One‐Component Lipid‐mRNA Complex (OncoLRC) for Cancer Vaccines
OncoLRC, a one‐component lipid‐mRNA complex, enables efficient spleen‐targeted delivery at an exceptionally low lipid‐to‐mRNA mass ratio (1.5:1), robustly activates immune responses, inhibits tumor growth, and synergizes with checkpoint blockade, presenting a next‐generation platform for mRNA vaccines.
Qimeng Yin +4 more
wiley +1 more source

